Chorioamnionitis medical therapy

Revision as of 18:47, 24 September 2015 by YazanDaaboul (talk | contribs)
Jump to navigation Jump to search

Chorioamnionitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chorioamnionitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chorioamnionitis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chorioamnionitis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chorioamnionitis medical therapy

CDC on Chorioamnionitis medical therapy

Chorioamnionitis medical therapy in the news

Blogs on Chorioamnionitis medical therapy

Directions to Hospitals Treating Chorioamnionitis

Risk calculators and risk factors for Chorioamnionitis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Antimicrobial therapy is indicated among patients with chorioamnionitis. The preferred regimen is a combination of ampicillin and gentamicin. Supportive therapy, such as antipyretics, may also be used.

Medical Therapy

Medical therapy for chorioamnionitis includes antimicrobial therapy and antipyretic therapy:

  • Preferred regimen: Ampicillin 2 g IV q6h AND (Gentamicin 1.5 mg/kg IV q8h OR Gentamicin 5 mg/kg IV q24h) until delivery THEN (Ampicillin 2 g IV in a single dose OR Gentamicin 5 mg/kg IV in a single dose) postpartum.
  • Alternative regimen, penicillin-allergic: Clindamycin 900 mg IV q8h AND (Gentamicin 1.5 mg/kg IV q8h OR Gentamicin 5 mg/kg IV q24h) until delivery THEN (Clindamycin 900 mg IV in a single dose OR Gentamicin 5 mg/kg IV in a single dose) postpartum.
  • Note (1): For patients with cesarean section who are not penicillin-allergic, add Metronidazole 500 mg IV in a single dose only after clamping the umbilical cord.
  • Note (2): For patients with cesarean section who are penicillin-allergic, Metronidazole should not be added post-partum.
  • Note (3): Chorioamnionitis is a contraindication to the administration of Corticosteroids. Women with intra-amniotic infection have traditionally been excluded from randomized trials of corticosteroid therapy.
  • 2. Supportive measures[1]

References

  1. 1.0 1.1 ACOG Committee on Practice Bulletins-Obstetrics (2007). "ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists". Obstet Gynecol. 109 (4): 1007–19. doi:10.1097/01.AOG.0000263888.69178.1f. PMID 17400872.
  2. Tita AT, Andrews WW (2010). "Diagnosis and management of clinical chorioamnionitis". Clin Perinatol. 37 (2): 339–54. doi:10.1016/j.clp.2010.02.003. PMC 3008318. PMID 20569811.

Template:WH Template:WS